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1. Introduction 
Schistosomiasis, also known as bilharziasis is caused by snail transmitted parasites of 
the genus schistosoma that inhabit the human vasculature.(1,2) It is among the most 
important parasitic diseases worldwide, with a significant socio economic impact(3). 
More than 200 million people are infected, and about 200,000 may die from the disease 
each year. On a global scale, one of thirty individuals has schistosomiasis(4). About 779 
million people live in endemic areas in the Middle East, South America, Caribbean, 
Southeast Asia and particularly sub-Saharan Africa(4). Extreme poverty, the 
unawareness of the risks, the inadequacy or total lack of public health facilities plus the 
unsanitary conditions in which millions of people lead their daily lives are all factors 
contributing to the risk of infection(5). 
During the past 20 years, much progress in combating the disease has been achieved based on 
World Health Organization recommendation strategies. Recent years have seen a notable 
decrease in the prevalence and morbidity of the disease in many endemic countries(6,7). Many 
countries of the EMR ( Eastern Mediterranean Region) namely Egypt, Iraq, Syria, Libya, Oman 
and Saudi  Arabia have now reached low schistosomiasis endemicity. For instance, the overall 
prevalence of schistosomiasis in  Egypt, was about 40% in (1967) before the national control 
program started by WHO (EMRO). In 2006, due to different control measures, the overall 
prevalence fell down to <3%. However there are still hot spot transmission foci with 
prevalence rate about 10%. Therefore lack of well structured prevention, control and 
elimination programs could lead to emergence or resurgence of the controlled disease. 
Schistosomiasis has been eliminated in Iran, Lebanon, Morocco and Tunisia, no new cases 
were detected over the past few years. Furthermore, WHO adopted a resolution calling on 
countries in low transmission areas, to sustain successful control activities in order to eliminate 
schistosomiasis(8) . In these conditions, where elimination of schistosomiasis is aimed for, case 
detection may pose a problem because the commonly used methods for the assessment of 
infection may lack necessary sensitivity to accurately determine the prevalence of 
schistosomiasis or of parasite burden(9,10). WHO(2001,2006)(11,12) asked for sensitive assays for 
active surveillance, specially in situations with no or very low transmission. 
Notwithstanding the large number of tests for diagnosing schistosomiasis, few have 
withstood tests of effectiveness, reproducibility, cross reactivity and predictive values 
(Rabello et al. 2002)(13). The diagnostic strategies traditionally rely on the detection of 
parasite eggs in stool (S. mansoni, S.japonicum)  or urine (S. haematobium) , antibody and 
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antigen detection techniques. Lier et al (2008)(14) reported that there is no satisfactory “gold 
standard” diagnostic test in low intensity infections.  
 
 
Fig. 1. Map showing Schistosomiasis Endemic Areas 
The Kato-Katz technique (15) is currently the most used method for fecal examination 
because it is quantitative, relatively inexpensive simple and fast. However, due to the small 
amount of stool examined (less than 50 mg), its sensitivity is logistically prohibitive to 
monitor regularly or comprehensively low or moderate infections. Due to random 
distribution effects, the analyzed sample may not contain eggs even if the disease is active. It 
is thus very difficult to achieve a conclusive confirmation of successful therapy. A 
significant increase in the sensitivity of the method is gained by microscopic examination of 
multiple samples, but this is a limiting procedure for field work(16,17). 
To overcome the current limitations with respect to diagnosis, the simultaneous use of 
different diagnostic methods, such as antibody detection followed by stool examination of 
seropositive individuals, has been applied to monitor the human population and to identify 
the small number of infected people once morbidity control is achieved.   Dias et al. (1989)(18) 
reported that in low endemic areas for schistosomiasis, serologic prevalence indices have 
shown to be 2 to 5 times higher than the parasitologic indices. In Pedro de Toledo, the 
prevalence was 55.5% by the IgG, and it was 22.8%,  by Kato-Katz method, with an infection 
intensity of 58.5 epg. Thus, the serologic prevalence was 2.6 times higher than the 
parasitologic prevalence. Noya et al(1999)(19) reported that  the serologic prevalence by IgG 
was 33.2%, which was 20 times higher than the parasitologic prevalence of 1.6%, obtained 
by Kato-Katz method, with an infection intensity of 40.9 epg.  
Burlandy- Soares et al (2003)(20) reported that  the high difference between serologic and 
parasitologic prevalence data is undoubtedly  due to the low diagnostic sensitivity of the 
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parasitologic methods. Other might be the presence of individuals who have developed 
immune response to S. mansoni antigens after exposure to cercariae, but without 
development of infection, or have been cured after chemotherapy and still present 
circulating antibodies. It is a well known fact that immediately after chemotherapy, the 
levels of specific antibodies rise stimulated by the death of the parasites and fall after. 
Although the serologic techniques (ELISA, IHA and IFT) are very efficient, they do not 
constitute part of the diagnostic routine for schistosomiasis, and also they are not 
commonly used in epidemiologic studies. Moreover, antibody detection methods often 
cannot distinguish between current and past infection and may also present a high level 
of cross-reactivity.  Blood collection is not easily applicable under field conditions, 
therefore this method is not recommended for field studies in endemic areas (Gryseels et 
al.,2006)(21). However, Kanamura et al (1998)(22) and Burlandy-Soares et al (2003)(20) 
reported that the introduction of serologic methods in epidemiological studies, 
identifying potential infection sources, may contribute towards the reduction of residual 
transmission. This procedure could be included in a national program for the control of 
schistosomiasis mansoni.  
Antigen based  assays , such as circulating cathodic antigen (CCA) detection in urine and 
circulating anodic antigen (CAA) in serum, have proven to be a valuable , field applicable 
method. Unfortunately, in low intensity of infection, most of the positive antigen levels were 
very close to the cut off value, which is a disadvantage for the epidemiological application 
of the assay. It was concluded that for the diagnosis of schistosomiasis in low endemic areas, 
circulating antigen detection should be considered as a complementary tool rather than a 
substitute for parasitological examination specially that the detection of CCA in urine and 
CAA in serum supplies additional information to determine more accurately the "true" 
prevalence of infection(23,24). 
To date, Percoll sedimentation technique was established as the technique of choice for 
diagnosis of S. mansoni  in low intensity conditions and post treatment(25) . This method 
always gives better and more consistent estimate than the Kato Katz , and efficiently detects 
low intensity infections up to 4 eggs /gm. Amongst Kato–Katz negative Schistosoma mansoni 
specimens in a hypoendemic area with a prevalence 0f 5%, Percoll detected 11% positive 
cases and  7% post treatment. The efficiency of Percoll is based on the fact that it depends on 
250 mg feces; one egg in the sediment would mean 4eggs/gm , whilst three Kato slides can 
diagnose up to 8 epg when only one egg is detected in one of the three slides examined. 
Moreover, detection of one to two eggs per fecal smear could be missed more easily within 
the fecal debris of Kato–Katz than the clear fields of the Percoll technique. Similar findings 
were reported by Eberl et al. (2002)(26), who found that the triple Kato–Katz examination on 
consecutive samples still missed 7.4% of all patients, whereas low egg numbers were 
detected efficiently only by Percoll technique. 
Pontes et al. (2002)(27) reported the first use of PCR for the diagnosis of S. mansoni DNA in 
fecal samples. PCR methods have shown high sensitivity and specificity for the detection of 
S. mansoni  DNA in stool samples, yet PCR gave negative results among few cases 
considered sure positives by microscopy (tables1,2) . Similar results were obtained by many 
authors(13,25,28,29,30).  
Table (1) shows that the analysis of discordant results revealed that 15 samples were 
positive only by the PCR and two samples were positive only by Kato Katz technique. 
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Kato-Katz faecal examination 
 Positive Negative Total 
PCR    
Positive 26 15 41 
Negative 2 24 26 
Total 28 39 67 
Kappa index: 0.511 (Gomes et al 2009)(30).  
Table 1. Comparative evaluation of the PCR and the Kato-Katz technique for the diagnosis 
of Schistosoma mansoni infection  
 
Percoll 
 Positive Negative Total 
PCR    
Positive 2 16 18 
Negative 7 52 59 
Total 9 68 77 
Kappa index = 0.009, P > 0.05 no agreement (Allam et al 2009)(25) 
Table 2. Agreement of the Percoll and PCR for the detection of Schistosoma mansoni cases 
negative after Kato–Katz technique 
Comparing the results of the 77 cases analyzed by PCR with their results by Percoll revealed 
that only two patients gave concordant positive results; seven cases positive by Percoll were 
negative by PCR (Table2).  
Pontes et al. (2003)(25) reported that missed cases after PCR were certainly misdiagnosed by 
the DNA amplification assay due to many factors such as: inhibition of the amplification 
reaction by fecal compounds and ⁄ or DNA degradation during transportation from the 
field, variation in egg output and uneven distribution in feces. 
Oliveira et al.(2010)(31) reported that PCR can be an important tool for detecting S. mansoni 
infection in individuals excreting few eggs in feces. Moreover, the determination of the 
infection through the detection of S. mansoni DNA in stool samples from seropositive  
individuals represents a new means of confirming the results of IgG-ELISA for 
schistosomiasis. Therefore, studies in this direction should be encouraged and extended. 
Also, PCR have shown promise in the detection of parasites in a variety of media. 
Qualitative techniques have been developed to detect the presence or absence of S. 
jabonicum and avian schistosome cercariae recovered from snail hosts, as well as S. mansoni 
cercariae in water(32).    
It was reported that conventional PCR requires several steps after DNA amplification, 
including electrophoresis or blotting and hybridization, which are limited in the number of 
samples that can be conveniently analyzed. A multiplex real-time PCR assay for the 
detection and quantification of S. mansoni and Schistosomal DNA in faecal samples was 
developed and evaluated as an alternative diagnostic method to study the epidemiology of 
schistosomiasis(33). Primers and probes targeting the cytochrome c oxidase gene were 
designed for species-specific amplification and were combined with an internal control. 
Using positive control DNA extracted from adult Schistosoma worms and negative control 
samples (n=150) with DNA from a wide range of intestinal microorganisms, the method 
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proved to be sensitive and 100% specific. For further evaluation, duplicate stool specimens 
with varying S. mansoni egg loads were collected in northern Senegal from pre-selected 
individuals (n=88). The PCR cycle threshold values, reflecting parasite-specific DNA loads 
in faeces, showed significant correlation with microscopic egg counts both for S. mansoni in 
stool and S. haematobium in urine. Although eggs of S. haematobium were not observed in 
stool samples, the presence of S. haematobium DNA was detected successfully. The 
Schistosoma detection rate of PCR (84.1%) was similar to that of microscopy performed on 
duplicate stool samples (79.5%). The simple fecal sample collection procedure and the high 
throughput potential of the multiplex real-time PCR provide a powerful diagnostic tool for 
epidemiological studies on schistosomiasis in remote areas. Moreover, it demonstrates high 
sensitivity, even in samples containing a single schistosoma egg in stool(33,43). 
When comparing the real-time PCR with microscopy-based assays, the PCR is less labour 
intensive when many samples are to be examined. The PCR method also has the advantage 
of being less influenced by observer variation/bias as compared to microscopy-based 
methods.  
More recently, Gomes et al (2006)(30) ,Hung et al (2008)(32)and lier et al (2009)(34) established 
and developed SYBR Green ( a fluorescent based technology) and Taq Man  probe real time 
PCR assays for the detection and quantification of schistosomal DNA. They reported that 
they are potentially useful for quantification of parasite burden in human infection.  
Gomes et al (2010)(35) reported development of the PCR-ELISA system for the detection of 
Schistosoma DNA in human feces as an alternative approach to diagnose light infections. The 
system permits the enzymatic amplification of a specific region of the DNA from minute 
amounts of parasite material. Using the proposed PCR-ELISA approach for the diagnosis of 
a population in an endemic area in Brazil, 30% were found to be infected, as compared with 
the 18% found by microscopic fecal examination. The genus specificity of PCR-ELISA was 
assessed with purified DNA from S. mansoni, S. haematobium, S. bovis, S. intercalatum, S. 
japonicum, S. magrebowiei and S. rhodaini adult worms. Considering the results obtained with 
the Schistosoma PCR-ELISA system based on two levels of intensity of infection (1–100 epg 
and >100 epg), according to the Kato-Katz stool examination method, the assay revealed the 
potential to be considered semi-quantitative, as the mean absorbance readings corresponded 
to the intensity of infection. The high sensitivity of the Schistosoma PCR-ELISA system was 
evidenced by the high number of positive samples in both groups. The advantage of PCR-
ELISA as compared to PCR-electrophoresis is that it makes use of standard equipment 
widely used for the processing of ELISAs, and the reagents used are easy to obtain 
commercially. Therefore, PCR-ELISA allows for the use of PCR-based DNA diagnosis for 
routine purposes in laboratories in less developed countries with fewer resources. 
Nowadays , we have many sensitive methods for schistosomiasis detection in areas of low 
endemicity. Percoll sedimentation technique as parasitologic test of choice. Conventional 
PCR as a molecular technique for detection of schistosoma eggs. It can be used to confirm 
the results of seropositives through the detection of schistosomiasis in stool samples. Real 
time PCR assays for detection and quantification of schistosomiasis. PCR ELISA as a 
semiquantitative technique for diagnosis of low intensity of schistosomiasis. 
Thus, as the prevalence and intensity decrease, the benefit of increased sensitivity using the 
molecular tests must be weighed against additional costs. Although the techniques require a 
complex laboratory infrastructure and specific funding it may be used by control programs 
targeting the elimination of schistosomiasis( Lier et al 2009)(34).  
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Fig. 2. Can schistosomiasis be eliminated? Fenwick et al(5). 
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